IGFL2 and breast carcinoma: KLF5’s proliferative and pro-survival effects are mediated by IGFL2-AS1 [33], and KLF5 promotes basal-like breast cancer by upregulating the expression of IGFL1 and cell growth and survival [34,35,36].